31 May 2021 - Medicines regularly not worth approving at asking price.
Ireland continues to trail most of western Europe in sanctioning use of new medicines for patients, according to an industry survey.
The study examined how quickly countries across Europe agreed access to 152 new drugs that came to market between 2016 and 2019. Access generally means that agreement has been reached on reimbursement for the medicine.